Viewing Study NCT00227734


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2025-12-26 @ 7:08 PM
Study NCT ID: NCT00227734
Status: COMPLETED
Last Update Posted: 2012-06-05
First Post: 2005-09-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
Sponsor: Swiss Cancer Institute
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: SAKK 41/04
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators